# Treatment of ppROM With Erythromycin vs. Azithromycin Trial

> **NCT03060473** · PHASE3 · TERMINATED · sponsor: **The University of Texas Medical Branch, Galveston** · enrollment: 21 (actual)

## Conditions studied

- Preterm Premature Rupture of Membranes (PPROM)

## Interventions

- **DRUG:** Azithromycin
- **DRUG:** Erythromycin
- **DRUG:** Ampicillin
- **DRUG:** Amoxicillin

## Key facts

- **NCT ID:** NCT03060473
- **Lead sponsor:** The University of Texas Medical Branch, Galveston
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-02-23
- **Primary completion:** 2023-12-08
- **Final completion:** 2023-12-08
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** Patient population that meets study criteria is insufficient to continue project in a reasonable amount of time. To continue is futile in resources, staff time, and effort.
- **Last updated:** 2024-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03060473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03060473, "Treatment of ppROM With Erythromycin vs. Azithromycin Trial". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT03060473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*